Skip to main content
Top
Published in:

Open Access 28-09-2024 | Retinoblastoma | Clinical Investigation

Outcomes of five cases of retinoblastoma with optic nerve invasion on imaging

Authors: Tamae Onishi, Sachiko Nishina, Tadashi Yokoi, Tomoyo Yoshida, Shion Hayashi, Hazuki Morikawa-Anzai, Noriyuki Azuma, Chikako Kiyotani, Keita Terashima, Takako Yoshioka, Hideki Ogiwara, Hiroshi Fuji, Masayuki Kitamura, Yoshiyuki Tsutsumi

Published in: Japanese Journal of Ophthalmology | Issue 6/2024

Login to get access

Abstract

Purpose

To investigate the timing of enucleation, treatment course, and outcome for retinoblastoma (RB) with optic nerve (ON) invasion on imaging.

Study design

Retrospective clinical study.

Methods

Of the 160 patients with RB who presented to the National Center for Child Health and Development in Japan between 2005 and 2022, ON invasion on imaging at the initial presentation was seen in five patients. The clinical, computed tomography (CT), and magnetic resonance imaging (MRI) findings, and treatment courses were reviewed retrospectively.

Results

MRI showed ON invasion in all five patients (three with unilateral RB, 2 with bilateral RB); in two patients CT detected no invasion. Enucleation was performed in four patients, three of whom underwent neoadjuvant therapy and one had a positive ON resection margin following the enucleation as initial treatment. One patient did not undergo enucleation due to cerebrospinal fluid dissemination. All enucleated patients underwent adjuvant chemotherapy. Four patients underwent radiotherapy. During follow-up (mean, 89.4 months), four patients survived and one died.

Conclusion

MRI is recommended to evaluate ON invasion and determine the timing of enucleation for RB. The appropriate choice of neoadjuvant or adjuvant therapy would be helpful to avoid radiotherapy for RB with ON invasion on imaging.
Literature
1.
go back to reference Dimaras H, Kinami K, Dimba EA, Gronsdhal P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012;379:1436–46.CrossRefPubMed Dimaras H, Kinami K, Dimba EA, Gronsdhal P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012;379:1436–46.CrossRefPubMed
2.
go back to reference The Global Retinoblastoma Study Group. The global retinoblastoma outcome study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022;10:e1128–40.CrossRefPubMedCentral The Global Retinoblastoma Study Group. The global retinoblastoma outcome study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022;10:e1128–40.CrossRefPubMedCentral
3.
go back to reference Daniels AB, Patel SN, Milam RW, Kohanim S, Friedman DL, Koyama T. Effect of intravenous chemotherapy regimen on globe salvage success rates for retinoblastoma based on disease class-a meta-analysis. Cancers (Basel). 2021;13:2216.CrossRefPubMed Daniels AB, Patel SN, Milam RW, Kohanim S, Friedman DL, Koyama T. Effect of intravenous chemotherapy regimen on globe salvage success rates for retinoblastoma based on disease class-a meta-analysis. Cancers (Basel). 2021;13:2216.CrossRefPubMed
4.
go back to reference Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Linn Murhee A, et al. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017;64:101002.CrossRef Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Linn Murhee A, et al. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017;64:101002.CrossRef
5.
go back to reference Chantada GL, Guitter MR, Fandiño AC, Raslawski EC, DeDavila MTG, Vaiani E, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of optic nerve. Pediatr Blood Cancer. 2009;52:218–22.CrossRefPubMed Chantada GL, Guitter MR, Fandiño AC, Raslawski EC, DeDavila MTG, Vaiani E, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of optic nerve. Pediatr Blood Cancer. 2009;52:218–22.CrossRefPubMed
6.
go back to reference Radhakrishanan V, Kashyap S, Pschker N, Sharma S, Pathy S, Mohanti BK, et al. Outcome, pathologic finings, and compliance in orbital retinoblastoma (international retinoblastoma staging system stage III) treated with neoadjuvant chemotherapy: a prospective study. Ophthalmology. 2012;119:1470–7.CrossRef Radhakrishanan V, Kashyap S, Pschker N, Sharma S, Pathy S, Mohanti BK, et al. Outcome, pathologic finings, and compliance in orbital retinoblastoma (international retinoblastoma staging system stage III) treated with neoadjuvant chemotherapy: a prospective study. Ophthalmology. 2012;119:1470–7.CrossRef
7.
go back to reference Künkele A, Wilm J, Holdt M, Lohman D, Bornfeld N, Eggert A, et al. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German retinoblastoma referral centre. Br J Ophthalmol. 2015;99:949–53.CrossRefPubMed Künkele A, Wilm J, Holdt M, Lohman D, Bornfeld N, Eggert A, et al. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German retinoblastoma referral centre. Br J Ophthalmol. 2015;99:949–53.CrossRefPubMed
8.
go back to reference Choucair ML, Brisse HJ, Freneaux P, Desjardins L, Dorfmüller G, Puget S, et al. Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion. Pediatr Blood Cancer. 2020;67:e27998.CrossRefPubMed Choucair ML, Brisse HJ, Freneaux P, Desjardins L, Dorfmüller G, Puget S, et al. Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion. Pediatr Blood Cancer. 2020;67:e27998.CrossRefPubMed
9.
go back to reference Zhao J, Feng Z, Leung G, Gallie BL. Retinoblastoma survival following primary enucleation by AJCC staging. Cancers (Basel). 2021;13:6240.CrossRefPubMed Zhao J, Feng Z, Leung G, Gallie BL. Retinoblastoma survival following primary enucleation by AJCC staging. Cancers (Basel). 2021;13:6240.CrossRefPubMed
10.
go back to reference Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276–80.CrossRefPubMed Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276–80.CrossRefPubMed
11.
go back to reference Okada K, Soejima T, Sakamoto H, Hirato J, Hara J. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: a report from the Japanese pediatric brain tumor consortium. Pediatr Blood Cancer. 2020;67:e28572.CrossRefPubMed Okada K, Soejima T, Sakamoto H, Hirato J, Hara J. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: a report from the Japanese pediatric brain tumor consortium. Pediatr Blood Cancer. 2020;67:e28572.CrossRefPubMed
12.
go back to reference Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202–8.CrossRefPubMed Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202–8.CrossRefPubMed
13.
go back to reference Okada S, Hongo T, Sakaguchi K, Suzuki K, Nishizawa S, Ohzeki T. Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma. Childs Nerv Syst. 2007;23:407–13.CrossRefPubMed Okada S, Hongo T, Sakaguchi K, Suzuki K, Nishizawa S, Ohzeki T. Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma. Childs Nerv Syst. 2007;23:407–13.CrossRefPubMed
14.
go back to reference Bellaton E, Bertozzi A, Behar C, Suzuki K, Nishizawa S, Ohzeki T. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol. 2003;87:327–9.CrossRefPubMedPubMedCentral Bellaton E, Bertozzi A, Behar C, Suzuki K, Nishizawa S, Ohzeki T. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol. 2003;87:327–9.CrossRefPubMedPubMedCentral
15.
go back to reference Chawla B, Chaurasia S, Sharma S, Pattebahadur R, Hasan F, Seth R, et al. Magnetic resonance imaging for tumor restaging after chemotherapy in retinoblastoma with optic nerve invasion. Ophthalmic Genet. 2018;39:584–8.CrossRefPubMed Chawla B, Chaurasia S, Sharma S, Pattebahadur R, Hasan F, Seth R, et al. Magnetic resonance imaging for tumor restaging after chemotherapy in retinoblastoma with optic nerve invasion. Ophthalmic Genet. 2018;39:584–8.CrossRefPubMed
16.
go back to reference Kim U, Rathi G, Chowdhary G, Srinavasan KG, Shanthi R, Prabhu Krishna RS. Accuracy of preoperative imaging in predicting optic nerve invasion in retinoblastoma: a retrospective study. Indian J Ophthalmol. 2019;67:2019–22.CrossRefPubMedPubMedCentral Kim U, Rathi G, Chowdhary G, Srinavasan KG, Shanthi R, Prabhu Krishna RS. Accuracy of preoperative imaging in predicting optic nerve invasion in retinoblastoma: a retrospective study. Indian J Ophthalmol. 2019;67:2019–22.CrossRefPubMedPubMedCentral
17.
go back to reference Chiranthan M, Meel R, Sharma S, Lomi N, Kashyap S, Bajaj MS. Can enhancement pattern in normal-sized optic nerves on magnetic resonance imaging better predict tumor invasion in retinoblastoma eyes? Ocul Oncol Pathol. 2023;9:107–14.CrossRefPubMedPubMedCentral Chiranthan M, Meel R, Sharma S, Lomi N, Kashyap S, Bajaj MS. Can enhancement pattern in normal-sized optic nerves on magnetic resonance imaging better predict tumor invasion in retinoblastoma eyes? Ocul Oncol Pathol. 2023;9:107–14.CrossRefPubMedPubMedCentral
Metadata
Title
Outcomes of five cases of retinoblastoma with optic nerve invasion on imaging
Authors
Tamae Onishi
Sachiko Nishina
Tadashi Yokoi
Tomoyo Yoshida
Shion Hayashi
Hazuki Morikawa-Anzai
Noriyuki Azuma
Chikako Kiyotani
Keita Terashima
Takako Yoshioka
Hideki Ogiwara
Hiroshi Fuji
Masayuki Kitamura
Yoshiyuki Tsutsumi
Publication date
28-09-2024
Publisher
Springer Japan
Published in
Japanese Journal of Ophthalmology / Issue 6/2024
Print ISSN: 0021-5155
Electronic ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-024-01112-z